Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/213387
Title: Prevalence of Potentially Inappropriate Prescriptions According to the New STOPP/START Criteria in Nursing Homes: A Systematic Review
Author: Díaz Planelles, Isabel
Navarro Tapia, Elisabet
García Algar, Óscar
Andreu-Fernández, Vicente
Keywords: Efectes secundaris dels medicaments
Residències de persones grans
Prescripció de medicaments
Morbiditat
Comorbiditat
Drug side effects
Old age homes
Drug prescribing
Morbidity
Comorbidity
Issue Date: 1-Feb-2023
Publisher: MDPI
Abstract: The demand for long-term care is expected to increase due to the rising life expectancy and the increased prevalence of long-term illnesses. Nursing home residents are at an increased risk of suffering adverse drug events due to inadequate prescriptions. The main objective of this systematic review is to collect and analyze the prevalence of potentially inadequate prescriptions based on the new version of STOPP/START criteria in this specific population. Databases (PubMed, Web of Science and Cochrane) were searched for inappropriate prescription use in nursing homes according to the second version of STOPP/START criteria. The risk of bias was assessed with the STROBE checklist. A total of 35 articles were assessed for eligibility. One hundred and forty nursing homes and more than 6900 residents were evaluated through the analysis of 13 studies of the last eight years. The reviewed literature returned prevalence ranges between 67.8% and 87.7% according to the STOPP criteria, according to START criteria prevalence ranged from 39.5% to 99.7%. The main factors associated with the presence of inappropriate prescriptions were age, comorbidities, and polypharmacy. These data highlight that, although the STOPP/START criteria were initially developed for community-dwelling older adults, its use in nursing homes may be a starting point to help detect more efficiently inappropriate prescriptions in institutionalized patients. We hope that this review will help to draw attention to the need for medication monitoring systems in this vulnerable population.
Note: Reproducció del document publicat a: https://doi.org/10.3390/healthcare11030422
It is part of: Healthcare, 2023, vol. 11, num.3, p. 422
URI: http://hdl.handle.net/2445/213387
Related resource: https://doi.org/10.3390/healthcare11030422
ISSN: 2227-9032
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
Articles publicats en revistes (BCNatal Fetal Medicine Research Center)

Files in This Item:
File Description SizeFormat 
860585.pdf565.81 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons